Advertisement

Journal of Neuro-Oncology

, Volume 129, Issue 1, pp 189–191 | Cite as

Comment on: Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?

  • André O. von Bueren
  • Clemens Seidel
  • Carsten Friedrich
Letter to the Editor
  • 187 Downloads

To the Editor,

We have read with great interest the article by Franceschi et al. on ‘‘Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients?’’ recently published in the ‘‘CLINICAL STUDY” section of the journal [1].

The authors have performed a retrospective analysis on 43 adult average-risk medulloblastoma patients. One of the main objectives of this analysis was to investigate the outcome of patients with regard of postoperative treatment (CSI alone versus CSI and chemotherapy). Some key findings of the publication and the treatment flow chart are shown in Fig. 1.

Keywords

Overall Survival Medulloblastoma Complete Staging Medulloblastoma Patient Professional Outcome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. 1.
    Franceschi E, Bartolotti M, Paccapelo A, Marucci G, Agati R, Volpin L, Danieli D, Ghimenton C, Gardiman MP, Sturiale C, Poggi R, Mascarin M, Balestrini D, Masotto B, Brandes AA (2016) Adjuvant chemotherapy in adult medulloblastoma: is it an option for average-risk patients? J Neurooncol. doi: 10.1007/s11060-016-2097-x Google Scholar
  2. 2.
    von Bueren AO, Friedrich C, von Hoff K, Kwiecien R, Muller K, Pietsch T, Warmuth-Metz M, Hau P, Benesch M, Kuehl J, Kortmann RD, Rutkowski S (2015) Metastatic medulloblastoma in adults: outcome of patients treated according to the HIT2000 protocol. Eur J Cancer 51:2434–2443CrossRefGoogle Scholar
  3. 3.
    Friedrich C, von Bueren AO, von Hoff K, Kwiecien R, Pietsch T, Warmuth-Metz M, Hau P, Deinlein F, Kuehl J, Kortmann RD, Rutkowski S (2013) Treatment of adult nonmetastatic medulloblastoma patients according to the paediatric HIT 2000 protocol: a prospective observational multicentre study. Eur J Cancer 49:893–903CrossRefPubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2016

Authors and Affiliations

  • André O. von Bueren
    • 1
    • 2
  • Clemens Seidel
    • 3
  • Carsten Friedrich
    • 3
  1. 1.University Medical Center GenevaGenevaSwitzerland
  2. 2.University Medical Center GoettingenGoettingenGermany
  3. 3.University Medical Center LeipzigLeipzigGermany

Personalised recommendations